Medical Condition News

RSS

Novel ‘Catch It’ smartphone app can help people manage their problems

In a joint project between the Universities of Liverpool and Manchester researchers have examined the initial trial of a smartphone application designed to help people manage their problems.

13 May 2016

Myocardial fibrosis linked to adverse cardiovascular outcomes in OSA patients

Myocardial fibrosis could be a future therapeutic target after researchers found it correlated with adverse cardiovascular outcomes in patients with obstructive sleep apnoea (OSA) referred for cardiac magnetic resonance (CMR).

13 May 2016

Study finds no link between weekend staffing levels and patient deaths

The ‘weekend effect’ – that patients admitted to hospital over the weekend are at an increased risk of death – overshadows a much more complex pattern of weekly changes in quality of care, which are unlikely to be addressed by simply increasing the availability of hospital doctors on Saturdays and Sundays, according to two new studies published in The Lancet.

13 May 2016

Genes linked to educational attainment expressed in the brain during prenatal development

An international group of 253 scientists has conducted one of the largest genetic studies to date and identified 74 genetic variants that are associated with the years of formal education that an individual completes.

13 May 2016

TSRI chemists identify and design potent therapeutic ‘warheads’ for different diseases

In a pair of related studies, chemists from the Florida campus of The Scripps Research Institute (TSRI) have identified and designed dozens of molecular “warheads” that not only can detect a key biomarker of cancer, but also could be developed into a potent new class of drug candidates for a range of diseases.

13 May 2016

BetterYou Magnesium Oil spray relieves migraine pain in 43-year old mum

A 43-year old mum of one from Bristol, who suffered from frequent painful migraines for almost a decade has found relief thanks to BetterYou™ Magnesium Oil spray.

From BetterYou Ltd 13 May 2016

Researchers identify out of control immune system linked to neurodegenerative diseases

AN out of control immune system has been identified as a possible cause of neurodegenerative diseases such as Alzheimer’s.

13 May 2016

WHO: Air pollution levels increase in low- and middle income cities

More than 80% of people living in urban areas that monitor air pollution are exposed to air quality levels that exceed the World Health Organization limits. While all regions of the world are affected, populations in low-income cities are the most impacted.

13 May 2016

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson’s disease

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system disorders, today announced the start of patient enrollment in a long-term safety study (trial 012) of the company’s continuously administered subcutaneous levodopa/carbidopa formulation used in both ND0612H and ND0612L.

13 May 2016

University of Derby introduces new MOOC to provide better knowledge on autism, Asperger’s and ADHD

A new Massive Open Online Course (MOOC) to educate anyone interested in learning more about autism, Asperger’s and Attention-Deficit/Hyperactivity Disorder (ADHD) has been launched by the University of Derby.

From University of Derby Online Learning 13 May 2016

Sleep hormone melatonin may be responsible for type 2 diabetes risk among overnight workers

A new experimental and clinical study from Lund University in Sweden shows that the sleep hormone melatonin impairs insulin secretion in people with a common gene variant.

13 May 2016

New research solves mystery of why cetuximab drug proved futile for many colorectal cancer patients

Cancer researchers have identified a marker that shows up in a blood test that determines which patients with colorectal cancer that has spread would benefit from receiving the drug cetuximab.

13 May 2016

General anesthesia affects heart muscle proteins and causes depressed heart function, study shows

Anesthesia is used every day, but surprisingly little is known about one of its most dangerous side effects--depressed heart function.

13 May 2016

Genetic change to non-DNA structures in cell can cause cancer

A mutation that affects the proteins that package DNA--without changing the DNA itself--can cause a rare form of cancer, according to new findings in this week's Science from researchers at The Rockefeller University.

13 May 2016

New way of understanding neurodegeneration may lead to novel treatments

University of Adelaide researchers have developed a new theory for the causes of dementia and other neurodegenerative diseases, involving an out-of-control immune system.

13 May 2016

Physical movements improve in patients after bariatric surgery

People who have their stomach size surgically reduced move around more and easier after weight loss surgery, a study has found.

13 May 2016

New E-Vac therapy may be promising treatment option for GI leaks

Gastroenterologists on the medical staff at Baylor University Medical Center at Dallas are evaluating a new procedure for patients with gastrointestinal (GI) leaks and perforations, a complication that can result from laparoscopic surgery on the esophagus, stomach and small intestines—and outcomes have been promising.

13 May 2016

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Up to now, research into pollen allergies has largely focused on allergens - those components of pollen that trigger hypersensitivity reactions. When it comes into contact with the nasal mucous membrane, however, pollen releases a host of other substances in addition to allergens.

13 May 2016

Gene therapy shows promise in treating glioblastoma

A team from the International School for Advanced Studies in Trieste has obtained very promising results by applying gene therapy to glioblastoma.

13 May 2016

Clinical study shows sitagliptin drug not effective in treating NAFLD

A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.

13 May 2016

Medical Condition News

Novel ‘Catch It’ smartphone app can help people manage their problems

Myocardial fibrosis linked to adverse cardiovascular outcomes in OSA patients

Study finds no link between weekend staffing levels and patient deaths

Genes linked to educational attainment expressed in the brain during prenatal development

TSRI chemists identify and design potent therapeutic ‘warheads’ for different diseases

BetterYou Magnesium Oil spray relieves migraine pain in 43-year old mum

Researchers identify out of control immune system linked to neurodegenerative diseases

WHO: Air pollution levels increase in low- and middle income cities

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson’s disease

University of Derby introduces new MOOC to provide better knowledge on autism, Asperger’s and ADHD

Sleep hormone melatonin may be responsible for type 2 diabetes risk among overnight workers

New research solves mystery of why cetuximab drug proved futile for many colorectal cancer patients

General anesthesia affects heart muscle proteins and causes depressed heart function, study shows

Genetic change to non-DNA structures in cell can cause cancer

New way of understanding neurodegeneration may lead to novel treatments

Physical movements improve in patients after bariatric surgery

New E-Vac therapy may be promising treatment option for GI leaks

Researchers investigate effects of non-allergenic components of pollen on allergy sufferers

Gene therapy shows promise in treating glioblastoma

Clinical study shows sitagliptin drug not effective in treating NAFLD

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News